mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.1 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.08 |
0.1 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.1 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.085 |
0.1 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.1 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.1 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |